-
1 × $2,190.00
-
1 × $1,018.00
-
2 × $723.00
-
2 × $1,139.00
-
1 × $1,377.00
-
1 × $2,390.00
-
1 × $3,286.00
-
3 × $1,970.00
-
1 × $471.00
-
1 × $2,436.00
-
1 × $876.00
-
1 × $7,614.00
-
2 × $2,076.00
-
2 × $897.00
-
1 × $560.00
-
1 × $1,345.00
-
2 × $4,968.00
-
1 × $4,091.00
-
1 × $2,805.00
-
1 × $466.00
-
1 × $6,406.00
-
1 × $2,184.00
-
1 × $827.00
-
2 × $388.00
-
3 × $1,038.00
-
2 × $570.00
-
1 × $816.00
-
2 × $1,394.00
-
1 × $960.00
-
1 × $1,843.00
-
1 × $2,790.00
-
1 × $427.00
-
1 × $1,125.00
-
1 × $391.00
-
1 × $897.00
-
1 × $1,224.00
-
1 × $1,068.00
-
1 × $1,534.00
-
1 × $709.00
-
1 × $457.00
-
1 × $25,527.00
-
2 × $613.00
-
1 × $5,861.00
-
1 × $740.00
-
1 × $8,704.00
-
1 × $2,184.00
-
1 × $1,819.00
-
1 × $2,929.00
-
1 × $20,652.00
-
1 × $2,039.00
-
1 × $416.00
-
1 × $435.00
-
1 × $441.00
-
1 × $454.00
-
1 × $4,119.00
-
1 × $1,848.00
-
1 × $2,219.00
-
1 × $5,773.00
-
2 × $1,311.00
-
2 × $2,218.00
-
1 × $2,832.00
-
1 × $13,006.00
-
1 × $4,273.00
-
1 × $3,237.00
-
1 × $2,302.00
-
1 × $5,458.00
-
1 × $2,009.00
-
1 × $784.00
-
1 × $466.00
-
1 × $2,776.00
-
1 × $404.00
-
1 × $2,184.00
-
1 × $2,492.00
-
1 × $554.00
-
1 × $1,191.00
-
2 × $5,820.00
-
1 × $492.00
-
1 × $7,392.00
-
1 × $1,548.00
-
1 × $2,900.00
-
1 × $2,057.00
-
1 × $1,010.00
-
1 × $4,807.00
-
1 × $1,092.00
This item can only ship to a medical or educational facility.
The new wireless BD Veritor™ Plus System gives health care providers and laboratorians in physician offices, clinics, hospitals and Integrated Delivery Networks (IDNs) with objective, lab-quality immunoassay test results within minutes. This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The new system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), COVID-19 (SARS-2-COV) and group A strep while the patient is still on site, which can enable faster decision making for an earlier intervention opportunity.
Features and Benefits
- Faster access to test results: Help inform appropriate and targeted treatment decisions.
- Improved Workflow: The BD Veritor™ Plus Analyzer improves workflow with an Analyze Now or Walk Away mode, providing test results (with a printenabled function) and aiding in decision making while the patient is onsite.
- Improved Traceability: The optional BD Veritor™ InfoScan module can scan 3 different identifiers (operator ID, specimen ID and test kit /lot) that can be locally recorded, printed or downloaded, and reduces hands-on time through automated documentation
- Modularity: Provides a unique solution to meet each testing site’s preference
- Advanced particle technology: Enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles.
- Adaptive read technology: Compensates for background and non-specific binding helps improve specificity to reduce false-positive results
- BD Veritor SARS-CoV-2 & Flu A+B Rapid Detection Kit (Included): The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
Materials Included
- BD Veritor™ Plus System Anaylzer
- 2 AA Batteries
- 2 SARS-CoV-2 & Influenza A + B Rapid Detection Kit (30 Tests/Kits)
- User manual
CPT Code
- 87804-QW: Infectious agent antigen detection by immunoassay with direct optical observation, influenza A
- National Average Reimbursement: $16.00
- 878704-59: Infectious agent antigen detection by immunoassay with direct optical observation, influenza B
- National Average Reimbursement: $16.00
- 87426 – Infectious agent antigen detection by immunoassay technique (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative, multiple-step method, severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19])